The Outcome of Fungal Pneumonia with Hematological Cancer
- Author:
Esma EREN
1
;
Emine ALP
;
Fatma CEVAHIR
;
Tuğba TOK
;
Ayşegül Ulu KILIÇ
;
Leylagül KAYNAR
;
Recep Civan YÜKSEL
Author Information
- Publication Type:Original Article
- From:Infection and Chemotherapy 2020;52(4):530-538
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Fungal pneumonia is a common infectious complication of hematological cancer (HC) patients. In this retrospective study, the objective was set to identify the risk factors and outcome of fungal pneumonia in adult HC patients.
Materials and Methods:This retrospective study was conducted with adult (>16 years) HC patients from January 2017 and December 2018.
Results:During the study period, of 181 patients included 76 were diagnosed with fungal pneumonia. The most common HC was identified as acute myeloid leukaemia (40%). Of the participating patients, 52 (29%) were hematopoietic stem cell transplant (HSCT) recipients.The median age of patients with fungal pneumonia was significantly greater: 57 vs. 48 (odds ratio [OR]: 1.08) and they had longer hospitalization durations (OR: 1.14). Overall, 37 patients (20%) died, and 28-day mortality was significantly greater among patients with fungal pneumonia than without fungal pneumonia (33% vs. 11%). The most significant risk factors for mortality in fungal pneumonia were identified as need of intensive care unit (ICU) (OR: 191.2, P <0.001) and the need of vasopressor support (OR:81.6, P <0.012). ICU-mortality was (88%).
Conclusion:Fungal pneumonia is a lethal complication in HC patients. Intensive care need is the most important predictive factor for mortality.
